+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6cnr | ||||||
|---|---|---|---|---|---|---|---|
| Title | aducanumab apo Fab | ||||||
Components |
| ||||||
Keywords | IMMUNE SYSTEM / antibody Fab fragment | ||||||
| Function / homology | Immunoglobulins / Immunoglobulin-like / Sandwich / Mainly Beta Function and homology information | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.09 Å | ||||||
Authors | Arndt, J.W. | ||||||
Citation | Journal: Sci Rep / Year: 2018Title: Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-beta. Authors: Arndt, J.W. / Qian, F. / Smith, B.A. / Quan, C. / Kilambi, K.P. / Bush, M.W. / Walz, T. / Pepinsky, R.B. / Bussiere, T. / Hamann, S. / Cameron, T.O. / Weinreb, P.H. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6cnr.cif.gz | 102 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6cnr.ent.gz | 76.5 KB | Display | PDB format |
| PDBx/mmJSON format | 6cnr.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 6cnr_validation.pdf.gz | 440.3 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 6cnr_full_validation.pdf.gz | 441.5 KB | Display | |
| Data in XML | 6cnr_validation.xml.gz | 19.4 KB | Display | |
| Data in CIF | 6cnr_validation.cif.gz | 28.2 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/cn/6cnr ftp://data.pdbj.org/pub/pdb/validation_reports/cn/6cnr | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 6co3C ![]() 4lf3S S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
| ||||||||
| Components on special symmetry positions |
|
-
Components
| #1: Antibody | Mass: 23228.732 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: ![]() |
|---|---|
| #2: Antibody | Mass: 24374.516 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: ![]() |
| #3: Chemical | ChemComp-SO4 / |
| #4: Water | ChemComp-HOH / |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 3.27 Å3/Da / Density % sol: 62.41 % |
|---|---|
| Crystal grow | Temperature: 297 K / Method: vapor diffusion, sitting drop Details: 19% PEG 3350 in 100 mM sodium acetate, and 300 mM lithium sulfate |
-Data collection
| Diffraction | Mean temperature: 100 K |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 31-ID / Wavelength: 0.987 Å |
| Detector | Type: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Oct 10, 2008 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.987 Å / Relative weight: 1 |
| Reflection | Resolution: 2.09→50 Å / Num. obs: 36105 / % possible obs: 99.3 % / Redundancy: 3.6 % / Rmerge(I) obs: 0.057 / Net I/σ(I): 20.3 |
| Reflection shell | Resolution: 2.09→2.16 Å / Rmerge(I) obs: 0.486 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 4LF3 Resolution: 2.09→46.5 Å / SU ML: 0.26 / Cross valid method: THROUGHOUT / σ(F): 1.37 / Phase error: 26.83 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.09→46.5 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
X-RAY DIFFRACTION
Citation





















PDBj






